IRCT20201022049108N1
Completed
Phase 3
Evaluation of the Efficacy of Rectal or Sub-linguinal Misoprostol concomitant with Oxytocin for Prevention of Postpartum Hemorrhage in women with preeclampsia
Karaj University of Medical Sciences0 sites128 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- severe pre-eclampsia.
- Sponsor
- Karaj University of Medical Sciences
- Enrollment
- 128
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •ALL pregnant mothers with severe pre\-eclampsia who referred to the Shahi Kamali educational center in the study period
- •Hospitalization for C\-section
- •Gestational age over 35 weeks
- •Having a healthy and alive fetus
- •Cephalic fetus
- •A maximum of 2 previous cesarean sections
- •Complete removal of the placenta after cesarean section
- •The age of 18\-45 years
Exclusion Criteria
- •Mothers with coagulation disorders
- •History of maternal blood disorders
- •Chronic hypertension
- •Placental adhesion such as placenta previa and ecrta
- •Placental abruption (overt and covert)
- •Complications or emergency during surgery
- •Mild pre\-eclampsia
- •Abnormal placenta
- •History of uterine rupture
- •High bleeding risk
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Assess the effect of Liquorice gel as local drug delivery agent for treatment of Chronic PeriodontitisCTRI/2024/05/067674Dr Diksha Gupta
Completed
Phase 4
Evaluating Sublingual immunotherapy in allergic RhinoconjunctivitisEar, Nose and ThroatEye DiseasesPACTR201901529431463Faculty of Medicine Zagazig University120
Completed
Not Applicable
Evaluation of the efficacy of rectal preparation from Hemoheal® Cream in patients with HemorrhoidHemorrohiod.Unspecified haemorrhoids with other complicationsIRCT2017091335460N1Vice Chancellor for Research, Kermanshah University of Medical Sciences40
Completed
Phase 4
ocal Drug Delivery for the treatment of Periodontal DiseasesHealth Condition 1: 3- AdministrationCTRI/2019/04/018697not applicable26
Completed
Not Applicable
Study on compare of sublingual, rectal and vaginal misoprostol for cervical priming 12 hours before hysteroscopyCondition 1: Patients who are candidates for hysteroscopy. Condition 2: Patients who are candidates for hysteroscopy.Noninflammatory disorder of uterus, unspecifiedInflammatory disease of uterus, unspecifiedIRCT201105296626N1Tabriz University of medical science120